Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien

Bavarian Nordic announced that its partner Eurofarma has submitted a marketing authorization application to Brazil's health authority Anvisa for CHIKV VLP, a chikungunya vaccine for individuals 12 years and older. This milestone represents a significant step in expanding vaccine access to one of the countries most affected by chikungunya, where over half of global cases and deaths occur.